Associate Director, GDO Business Operations at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor’s degree required
6-8 years’ experience in the pharmaceutical industry with direct involvement in communications and change management
Proven ability to think strategically and synthesize complex information across multiple initiatives
Demonstrated ability to plan, develop, and execute communications in a large organization
Experience managing external agencies/vendors and ensuring alignment with internal objectives
Strong interpersonal and collaboration skills
Exceptional written, verbal, and presentation skills
No supervisory or direct team leadership responsibilities
Onsite presence required in Lawrenceville, NJ

Responsibilities

Partner with the GDO leadership team to prioritize, synthesize, and deliver communications supporting key initiatives
Coordinate leadership team meeting topics and agendas, including pre-read materials and managing follow-up actions to ensure timely execution of decisions
Collaborate with GDO Excellence team to leverage the change management network (e.g., Sparks) and drive communication through internal campaigns (e.g., Just GO Do It, Breaking Barriers)
Lead the development and execution of strategic communications supporting GDO initiatives
Connect the dots across multiple programs to produce clear, cohesive messages for large internal audiences
Accountable for the communications planning and delivery across multiple internal channels (e.g., meetings, LT walking decks, emails, newsletters, portals)
Coordinate with internal stakeholders to ensure communications alignment and timely dissemination
Oversee vendor relationships with external communications agencies, ensuring delivery per expectations and standards
Support change management efforts within the organization through effective communication strategies
Measure effectiveness of communication campaigns and adjust strategies as needed to maximize impact
Ensure all communications meet compliance and brand guidelines

Skills

Strategic Communications

Change Management

Cross-Functional Collaboration

Leadership Communications

Stakeholder Management

Internal Communications

Message Synthesis

Vendor Management

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free